Non-Small Cell Lung Cancer Market in Asia-Pacific to Hit $4.9 Billion by 2022; Finds New Report
The Non-Small Cell Lung Cancer (NSCLC) market in Asia-Pacific (APAC) countries, including India, China, Australia, South Korea, and Japan, will experience strong growth from $2.7 billion in 2015 to $4.9 billion by 2022, representing a compound annual growth rate of 8.7%, according to new report.
View full press release